South Carolina General Assembly
125th Session, 2023-2024

Download This Bill in Microsoft Word Format

Indicates Matter Stricken
Indicates New Matter

S. 471

STATUS INFORMATION

Senate Resolution
Sponsors: Senator Shealy
Document Path: SR-0253KM-VC23.docx

Introduced in the Senate on January 31, 2023
Currently residing in the Senate

Summary: Tardive Dyskinesia (TD) Awareness Week

HISTORY OF LEGISLATIVE ACTIONS

Date Body Action Description with journal page number
1/31/2023 Senate Introduced (Senate Journal-page 6)
1/31/2023 Senate Referred to Committee on Medical Affairs (Senate Journal-page 6)
2/1/2023 Scrivener's error corrected
2/7/2023 Senate Recalled from Committee on Medical Affairs (Senate Journal-page 4)
2/8/2023 Senate Adopted (Senate Journal-page 52)
2/8/2023 Scrivener's error corrected

View the latest legislative information at the website

VERSIONS OF THIS BILL

01/31/2023
02/01/2023
02/07/2023
02/08/2023



Recalled

February 7, 2023

S. 471

Introduced by Senator Shealy

S. Printed 02/07/23--S.   [SEC 2/8/2023 12:01 PM]

Read the first time January 31, 2023

________

A senate RESOLUTION

TO RECOGNIZE May 1-7, 2023, AS "Tardive Dyskinesia Awareness Week" IN SOUTH CAROLINA.

Whereas, many people with serious mental health conditions, such as bipolar disorder, major depression, schizophrenia, and schizoaffective disorder, or gastrointestinal disorders, including gastroparesis, nausea, and vomiting, may be treated with medications that work as dopamine receptor blocking agents (DRBAs), including antipsychotics; and

Whereas, while ongoing treatment with these medications can be necessary, prolonged use can also lead to tardive dyskinesia (TD), an involuntary movement disorder that is characterized by uncontrollable, abnormal, and repetitive movements of the face, torso, or other body parts; and

Whereas, it is estimated that TD affects approximately six hundred thousand people in the United States. Approximately seventy percent of people with TD have not been diagnosed, making it important to raise awareness about the symptoms and impact of TD because even mild symptoms of TD can have physical, social, and emotional consequences; and

Whereas, it is important that people taking DRBA medication be monitored for TD. Regular screening for TD in these patients is recommended by the American Psychiatric Association; and

Whereas, clinical research has led to the availability of two treatments for adults with TD; and

Whereas, it is beneficial to the health and safety of our State that the Senate raise awareness of Tardive Dyskinesia in the public and medical community. Now, therefore,

Be it resolved by the Senate:

That the members of the South Carolina Senate, by this resolution, recognize May 1-7, 2023, as "Tardive Dyskinesia Awareness Week" in South Carolina.

----XX----

This web page was last updated on January 11, 2024 at 5:10 PM